Clinical Trial Update: Active Drug Comparative, Multi-center, phase3 Clinical Study to Evaluate the Efficacy and Safety of PG201 in Osteoarthritis Patients [Phase 3]

View source ↗

Summary

A Phase 3, multi-center trial evaluating the efficacy and safety of PG201 in osteoarthritis of the knee has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• PG201

Snippet

Sponsor: PMG Pharm Co., Ltd | Conditions: Osteoarthritis of the Knee | Phase 3 | Status: COMPLETED